| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
David F Hoffmeister is Director at GKOS and has filed Form 4s across 4 companies. David F Hoffmeister's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $13.6M at current prices.
The biggest single holding is GKOS (~$11.5M) as Director.
David F Hoffmeister has 52 Form 4 filings on record from July 2015 to September 2026, across 4 companies: Director at StepStone Group (STEP), 2020–2026; Director at Glaukos (GKOS), 2015–2026; Director at ICU Medical (ICUI), 2018–2026, and 1 more.
The 68 reported transactions were 35 stock awards, 21 option or other derivative awards, 11 option exercises and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $997K and no sales.
The only open-market purchase was 22,500 shares of STEP at an average $44.29 on May 30, 2024, about $997K. Twelve months later STEP was up 30%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 30, 2024 | STEP Stepstone Group Inc. | Director | Buy | 22,500 | $44.29 | $996,525.00 | +96.3% | +20.5% | +30.5% |